Committee for Medicinal Products for Human Use
Teclistamab Receives Positive Opinion From EMA for Adults with R/R Myeloma
Leah SherwoodMyeloma | November 22, 2022
The EMA’s CHMP recommendation is based on positive results from the multicohort, open-label...
Read More
EMA Recommends Conditional Approval of Mosunetuzumab for Follicular Lymphoma
Kerri FitzgeraldAggressive B-Cell Lymphoma | November 14, 2022
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use recommended the conditional approval ...
Read More
Advertisement
Advertisement
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    Editorial Board

    About Us

    Terms of Use

    Advertising

    Privacy Policy

    Our Network

    MashupMD

    GU Oncology Now

    Cancer Nursing Today

    Urban Health Today

    DocWire News

    Connect

    eNewsletters

    Calendar of Events

    Contact Us

    Contribute

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |